Moderna's stock fell by 7% as traders booked profits following a significant year-to-date surge, with BioNTech and Merck also experiencing declines. In contrast, Tracsis stock saw a notable surge in its value.

Experts provide recommendations on which companies to buy, sell, or hold this week, focusing on Tracsis, Keystone Law Group, and Card Factory. This analysis offers guidance for investors on specific stock performances.

Tracsis shares saw a significant jump after the company announced its full-year results were in line with market estimates.

A GSK drug has received approval in Japan, while Tracsis reports its trading performance is in line with expectations.